AstraZeneca - 2/8

Entry	Author	Date	Location
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster	Luke Timmerman	10/26/10	Seattle
Compendia Bioscience Morphs Into Big Pharma’s Cancer Genomics Partner	Ryan McBride	10/21/10	Detroit
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis	Luke Timmerman	10/20/10	San Diego
Necessity is the Mother of Stratification: Personalized Medicine is Getting Real	Don Rule	09/30/10	Seattle
Rigel Nabs $25M From AstraZeneca	Luke Timmerman	09/29/10	San Francisco
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer	Luke Timmerman	09/27/10	Seattle
Rigel Arthritis Drug Passes Trial	Luke Timmerman	09/23/10	San Francisco
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010	Luke Timmerman	09/20/10	San Francisco
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer	Ryan McBride	08/19/10	Boston
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader	Luke Timmerman	08/17/10	San Francisco
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News	Erin Kutz	07/02/10	Boston
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build Pipeline	Ryan McBride	06/28/10	Boston
Future Biotech Winners Will Help Nurses Clean up Less (Stuff), Says Roger Longman	Luke Timmerman	06/28/10	National
The Genomics Comeback	Sylvia Pagán Westphal	06/10/10	National
Is it Time for the FDA to Chime in on Drug Company Tweets?	Sylvia Pagán Westphal	05/26/10	National
Lycera Keeps Its Investors Happy, Snags $11M to Pursue New Autoimmune Drugs	Luke Timmerman	04/28/10	Detroit
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy	Luke Timmerman	02/16/10	Boston
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News	Erin Kutz	02/03/10	Boston
Flexion Snags Pfizer Bucks, Three Pharma Deals, For New Drug Model	Luke Timmerman	01/29/10	Boston
Vertex’s Matt Emmens on His Journey From Security Guard to CEO	Luke Timmerman	01/27/10	Boston
Intellikine Tests First Cancer Drug in Humans, Just Two Years After Opening Labs	Luke Timmerman	01/05/10	San Diego
Novexel Offers Exit to Atlas and Abingworth	Ryan McBride	12/24/09	Boston
Epizyme Tacks On Extra $8M Financing For Drugs that Turn Genes On or Off	Luke Timmerman	12/08/09	Boston
Santarus Shares Boom on FDA Approval of Over-the-Counter Heartburn Drug	Luke Timmerman	12/01/09	San Diego
Why is Pharma Betting So Big on Innovation in Boston?	Luke Timmerman	10/27/09	Boston
Autism Gets a Boost: Seaside Therapeutics Raises $30M To Develop First Drugs That Might Work	Luke Timmerman	09/17/09	Boston
Acceleron Aims for Anemia Cure, Mascoma to Pump Out Biofuels For Chevron, Genzyme Chief to Head Boston Fed, & More Boston-Area Life Sciences News	Rebecca Zacks	09/16/09	Boston
AstraZeneca Plans Local Job Cuts, Report Says	Ryan McBride	09/11/09	Boston
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic	Luke Timmerman	08/26/09	Boston
Seattle Genetics Snags Milestone	Luke Timmerman	08/10/09	Seattle
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster

Luke Timmerman

10/26/10

Seattle

Compendia Bioscience Morphs Into Big Pharma’s Cancer Genomics Partner

Ryan McBride

10/21/10

Detroit